To better understand how the field is evolving and where it might go next DDN spoke with Jan Jezek, Chief Scientific Officer at Arecor Therapeutics, about the scientific challenges, delivery innovations, and future opportunities surrounding GLP-1 therapies
doi:10.1080/01635581.2011.523494
While further research is needed to fully elucidate the long-term effects and optimal formulations of liposomal cosmetics, their current applications and potential for future development suggest a promising role in the skincare market [6]
Zepbound (tirzepatide): Zepbound, like Wegovy, is specifically approved as a weight loss medication
20 In 1953, Leroy Stevens discovered that spontaneous testicular teratomas occurred in approximately 1% of the 129-strain male mice they studied, with no significant age-related variation in frequency
Should I lower my retatrutide dose if my heart rate increases